During the past decade, Haaglanden Medisch Centrum conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 13 clinical trials were completed, i.e. on average, 16.9% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 6 clinical trials were completed. i.e. 18.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Haaglanden Medisch Centrum" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 16 trials, followed by "Leiden University Medical Center" with 13 trials sponsored, "The Netherlands Cancer Institute" with 11 trials sponsored, "Erasmus Medical Center" with 8 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 8 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Haaglanden Medisch Centrum" #1 collaborator was "Medical Center Haaglanden" with 17 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 13 trials as a collaborator, "Erasmus Medical Center" with 12 trials as a collaborator, "Leiden University Medical Center" with 9 trials as a collaborator and "Dutch Cancer Society" with 6 trials as a collaborator. Other collaborators include 236 different institutions and companies that were collaborators in the rest 180 trials.

According to Clinical.Site data, the most researched conditions in "Haaglanden Medisch Centrum" are "Breast Cancer" (9 trials), "Brain and Central Nervous System Tumors" (5 trials), "Glioblastoma" (4 trials), "Prostate Cancer" (4 trials) and "Pulmonary Embolism" (4 trials). Many other conditions were trialed in "Haaglanden Medisch Centrum" in a lesser frequency.

Most popular intervention types in "Haaglanden Medisch Centrum" are "Drug" (61 trials), "Procedure" (23 trials), "Other" (22 trials), "Device" (15 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "radiation therapy" (5 trials), "temozolomide" (4 trials), "Bevacizumab" (3 trials) and "Temozolomide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Haaglanden Medisch Centrum" are 110 trials for "All" genders, 12 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 46 active trials in "Haaglanden Medisch Centrum". 2 are not yet recruiting, 24 are recruiting, 19 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 57 completed trials in Haaglanden Medisch Centrum, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Haaglanden Medisch Centrum, 3 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 35 trials that are defined as “Not Applicable".

Haaglanden Medisch Centrum has several departments that took part in Clinical trials: "MC Haaglanden; Oncologie" - 2 trials